Immutep targets $100m for lung cancer drug trial tests
Immutep has launched a capital raise aiming to boost its war chest by $100 million to progress late stage trials for lung cancer sufferers.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FTH | Ann: Voluntary De-Listing of FTH from the Official List of ASX | 24/12/19 | 6 | 4.9K | |||
|
|||||||
FTH | Ann: Removal from Official List of ASX | 24/04/15 | 1 | 1.4K | |||
|
|||||||
FTH | Ann: Resignation & Appointment of Director & Company Secretary | 26/03/15 | 3 | 2.3K | |||
|
|||||||
FTH | Ann: Results of Meeting | 25/03/15 | 0 | 593 | |||
|
|||||||
FTH | Ann: Chairman's Address at AGM | 25/03/15 | 0 | 649 | |||
|
|||||||
FTH | Ann: Half Yearly Report | 02/03/15 | 0 | 700 | |||
|
|||||||
FTH | Ann: Change of Registered office address | 24/02/15 | 0 | 497 | |||
|
|||||||
FTH | Ann: Notice of Annual General Meeting/Proxy Form | 24/02/15 | 0 | 394 | |||
|
See All Discussions